<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01077869</url>
  </required_header>
  <id_info>
    <org_study_id>2009/621</org_study_id>
    <nct_id>NCT01077869</nct_id>
  </id_info>
  <brief_title>A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis</brief_title>
  <official_title>A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the feasibility of optical imaging and FDG-PET in the evaluation of
      radiation-induced mucositis will be evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    poor recruitment rate
  </why_stopped>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of optical imaging in the evaluation of radiation-induced mucositis.</measure>
    <time_frame>weekly assessment during 7 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility of FDG-PET in the evaluation of radiation-induced mucositis.</measure>
    <time_frame>2 weeks after radiotherapy</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Squamous Cell Carcinoma of the Oral Cavity</condition>
  <condition>Oropharynx Metastases</condition>
  <condition>Lymph Metastases</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endoscopic examination</intervention_name>
    <description>on a weekly basis during 7 weeks</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FDG-PET</intervention_name>
    <description>once pre-radiotherapy and once 2 weeks after initiation of radiotherapy</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Squamous cell carcinoma of the oral cavity, oropharynx and lymph node metastases from
        unknown primary tumor.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non-operated histologically confirmed squamous cell carcinoma of the oral cavity,
             oropharynx (except the posterior wall) and lymph node metastases from the unknown
             primary tumor (CUP)

          -  Stage T1-4; Tx N+ for the CUP

          -  Multidisciplinary Group of Head and Neck Tumors at Ghent University Hospital decision
             of radical radiotherapy (±concurrent chemotherapy)

          -  Informed consent obtained, signed and dated before specific protocol procedures.

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Pregnant or lactating women

          -  Active infection or fistula in the oral/oropharyngeal mucosa

          -  Previous cancer of the oral cavity and the oropharynx

          -  Prior head-and-neck radiotherapy

          -  Expectation of non-compliance with the study protocol

          -  Known allergy for topical anesthetics (Xylocaïne)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>wilfried De Neve, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.uzgent.be</url>
    <description>website University Hospital Ghent</description>
  </link>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2010</study_first_submitted>
  <study_first_submitted_qc>February 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2010</study_first_posted>
  <last_update_submitted>May 25, 2011</last_update_submitted>
  <last_update_submitted_qc>May 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 26, 2011</last_update_posted>
  <responsible_party>
    <name_title>Wilfried De Neve, MD, PhD</name_title>
    <organization>University Hospital Ghent</organization>
  </responsible_party>
  <keyword>oropharynx and lymph node metastases from an unknown primary tumor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Mucositis</mesh_term>
    <mesh_term>Stomatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

